These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3191355)

  • 1. Oxybutynin: is it safe?
    Baigrie RJ; Kelleher JP; Fawcett DP; Pengelly AW
    Br J Urol; 1988 Oct; 62(4):319-22. PubMed ID: 3191355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can oxybutynin cause peripheral neuropathy?
    Patel HR; Albehussi S; Arya M; Miller RA
    J Urol; 2002 Aug; 168(2):646. PubMed ID: 12131334
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability.
    Moore KH; Hay DM; Imrie AE; Watson A; Goldstein M
    Br J Urol; 1990 Nov; 66(5):479-85. PubMed ID: 2249115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of oxybutynin in urological practice.
    Kirkali Z; Whitaker RH
    Int Urol Nephrol; 1987; 19(4):385-91. PubMed ID: 3429165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Instability of the detrusor muscle. Treatment with oxybutynin chloride (ditropan)].
    Perales Cabanas L; Tallada Buñuel M; Romero Maroto J; Escribano Patiño G
    Actas Urol Esp; 1986; 10(6):481-6. PubMed ID: 3825651
    [No Abstract]   [Full Text] [Related]  

  • 7. A benefit-risk assessment of extended-release oxybutynin.
    Michel MC
    Drug Saf; 2002; 25(12):867-76. PubMed ID: 12241127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of unstable bladder with oxybutynin hydrochloride. Our clinical experience in 80 cases].
    Alladio F; Arena G; Ferrando U; Pigato M; Sesia G
    Minerva Urol Nefrol; 1987; 39(4):359-62. PubMed ID: 3451374
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Schaefer W
    Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Tapp AJ; Cardozo LD; Versi E; Cooper D
    Br J Obstet Gynaecol; 1990 Jun; 97(6):521-6. PubMed ID: 2198921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oxybutynin chloride on bladder spasm following transurethral surgery.
    Wein AJ; Hanno PM; Raezer DM; Benson GS
    Urology; 1978 Aug; 12(2):184-6. PubMed ID: 358527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oxybutynin chloride in pediatrics: extenuating circumstances].
    Aubert D
    Arch Fr Pediatr; 1988 May; 45(5):375-6. PubMed ID: 3415420
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxybutynin efficacy in the treatment of primary enuresis.
    Lovering JS; Tallett SE; McKendry JB
    Pediatrics; 1988 Jul; 82(1):104-6. PubMed ID: 3288951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxybutynin in the treatment of early detrusor instability after transurethral resection of the prostate.
    Iselin CE; Schmidlin F; Borst F; Rohner S; Graber P
    Br J Urol; 1997 Jun; 79(6):915-9. PubMed ID: 9202559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
    Kasabian NG; Vlachiotis JD; Lais A; Klumpp B; Kelly MD; Siroky MB; Bauer SB
    J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo.
    Thüroff JW; Bunke B; Ebner A; Faber P; de Geeter P; Hannappel J; Heidler H; Madersbacher H; Melchior H; Schäfer W
    J Urol; 1991 Apr; 145(4):813-6; discussion 816-7. PubMed ID: 2005707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose oxybutynin for the unstable bladder.
    Malone-Lee J; Lubel D; Szonyi G
    BMJ; 1992 Apr; 304(6833):1053. PubMed ID: 1586797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.